THIS ARTICLE HAS BEEN RETRACTED: Point‐of‐care (POC) testing of lactate in the intensive care patient

Background: Point‐of‐care (POC) monitoring may facilitate diagnostic and therapeutic interventions in the critically ill. In a prospective study reliability and costs of two POC lactate testing devices were compared to the central laboratory lactate monitoring method.

[1]  E. Spitznagel,et al.  Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. , 1994, The Journal of thoracic and cardiovascular surgery.

[2]  J. Falk,et al.  Lactic acidosis in critical illness , 1992, Critical care medicine.

[3]  S F Goran,et al.  Current nursing practice of point-of-care laboratory diagnostic testing in critical care units. , 1995, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[4]  J. Siegel,et al.  Validation of a hand-held lactate device in determination of blood lactate in critically injured patients. , 1998, Critical care medicine.

[5]  J E Parrillo,et al.  Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis. , 1987, Critical care medicine.

[6]  J. Vincent,et al.  Evaluation of a new, rapid lactate analyzer in critical care , 1999, Intensive Care Medicine.

[7]  R. Bellomo,et al.  Resuscitation from severe hemorrhage. , 1996, Critical care medicine.

[8]  K. High,et al.  Decentralized testing for prothrombin time and activated partial thromboplastin time using a dry chemistry portable analyzer. , 1993, Archives of pathology & laboratory medicine.

[9]  T. Fabian,et al.  Prognostic value of blood lactate, base deficit, and oxygen-derived variables in an LD50 model of penetrating trauma. , 1999, Critical care medicine.

[10]  G. Kost,et al.  New whole blood analyzers and their impact on cardiac and critical care. , 1993, Critical reviews in clinical laboratory sciences.

[11]  Point-of-care testing in the intensive care unit. The intensive care physician's perspective. , 1995, American journal of clinical pathology.

[12]  J. Vincent,et al.  Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock. , 1991, Chest.

[13]  J H Keffer.  Economic considerations of point-of-care testing. , 1995, American journal of clinical pathology.

[14]  G. Zaloga.  Evaluation of bedside testing options for the critical care unit. , 1990, Chest.

[15]  Max H. Weil,et al.  Excess Lactate: An Index of Reversibility of Shock in Human Patients , 1964, Science.

[16]  Joseph Foss,et al.  Comparing Methods of Clinical Measurement: Reporting Standards for Bland and Altman Analysis , 2000, Anesthesia and analgesia.

[17]  C. Cairns,et al.  Evidence for early supply independent mitochondrial dysfunction in patients developing multiple organ failure after trauma. , 1997, The Journal of trauma.

[18]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[19]  B. Oberhardt,et al.  Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. , 1991, Clinical chemistry.

[20]  T. Scalea,et al.  Lactate clearance and survival following injury. , 1993, The Journal of trauma.

[21]  De Cresce Rp,et al.  Financial justification of alternate site testing. , 1995 .